AKINA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 5,575 | 3,878 | 5,813 | 3,552 | 3,253 | 4,392 | 4,842 | 5,882 |
| Profit before tax | -575 | -1,390 | 61 | -1,631 | -10,229 | -4,923 | -5,794 | -4,928 |
| Net profit | -575 | -1,390 | 57 | -1,631 | -10,229 | -4,923 | -5,794 | -4,928 |
| Equity | 3,126 | 1,736 | 1,793 | 162 | -10,067 | -14,990 | -20,784 | -25,712 |
| Liabilities | 10,061 | 9,610 | 4,952 | 6,537 | 10,192 | 15,020 | 20,847 | 26,086 |
| Non-current assets | 167 | 167 | 167 | 167 | 125 | 1 | 1 | 371 |
| Current assets | 13,020 | 11,179 | 6,578 | 6,532 | 0 | 29 | 62 | 3 |
| Total assets | 13,187 | 11,346 | 6,745 | 6,699 | 125 | 30 | 63 | 374 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -60.1% | -30.4% | +49.9% | -38.9% | -8.4% | +35.0% | +10.2% | +21.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -4.4% | -12.3% | 0.8% | -24.3% | -8183.2% | -16410.0% | -9196.8% | -1317.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -18.4% | -80.1% | 3.2% | -1006.8% | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -10.3% | -35.8% | 1.0% | -45.9% | -314.4% | -112.1% | -119.7% | -83.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -10.3% | -35.8% | 1.0% | -45.9% | -314.4% | -112.1% | -119.7% | -83.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.2 | 5.5 | 2.8 | 40.4 | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 2,788 | 1,939 | 3,671 | 3,552 | 3,253 | 4,392 | 4,842 | 5,882 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
AKINA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-11-18 | 2025-12-07 | 0.49 |
| 2025-10-23 | 2025-11-11 | 0.49 |
| 2025-10-07 | 2025-10-07 | 97.90 |
| 2025-09-24 | 2025-10-06 | 98.04 |
| 2025-09-16 | 2025-09-23 | 117.30 |
| 2024-03-18 | 2024-03-25 | 11.87 |
| 2024-02-19 | 2024-03-04 | 11.87 |
| 2024-01-23 | 2024-02-06 | 1.87 |
| 2024-01-16 | 2024-01-22 | 1.83 |
| 2023-12-18 | 2024-01-10 | 1.83 |
| 2023-11-16 | 2023-12-10 | 1.83 |
| 2023-10-30 | 2023-11-08 | 1.83 |
| 2023-10-26 | 2023-10-29 | 1.80 |
| 2023-10-25 | 2023-10-25 | 1.83 |
| 2023-10-17 | 2023-10-24 | 1.80 |
| 2023-09-18 | 2023-10-10 | 1.80 |
| 2023-08-17 | 2023-09-07 | 1.80 |
| 2023-07-26 | 2023-08-08 | 1.80 |
| 2023-07-24 | 2023-07-25 | 1.86 |
| 2023-06-16 | 2023-06-28 | 122.63 |
| 2023-05-16 | 2023-06-11 | 122.63 |
| 2023-05-02 | 2023-05-14 | 33.30 |
| 2023-04-27 | 2023-04-28 | 33.30 |
| 2023-04-26 | 2023-04-26 | 33.19 |
| 2023-04-25 | 2023-04-25 | 33.30 |
| 2023-04-19 | 2023-04-24 | 33.19 |
| 2023-04-18 | 2023-04-18 | 99.67 |
| 2023-02-06 | 2023-02-16 | 0.15 |
| 2023-01-17 | 2023-02-03 | 0.15 |
| 2022-12-16 | 2023-01-15 | 0.15 |
| 2022-11-21 | 2022-12-13 | 0.15 |
| 2022-11-17 | 2022-11-18 | 0.15 |
| 2022-10-31 | 2022-11-13 | 0.15 |
| 2022-05-17 | 2022-06-13 | 0.13 |
| 2022-04-25 | 2022-05-10 | 0.13 |
| 2022-01-28 | 2022-02-13 | 0.26 |
| 2022-01-18 | 2022-01-19 | 146.19 |
| 2021-10-22 | 2021-11-15 | 0.04 |
| 2021-10-18 | 2021-10-19 | 146.19 |
AKINA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
AKINA, UAB, code 136019936, is a Private Limited Liability Company operating in medical specialists activities. In financial year 2025, revenue increased to €5.9K from €4.8K in 2024 and €4.4K in 2023, indicating a steady upward trend over the last two years. Even so, the company remained loss-making: net profit was -€4.9K in 2025, after -€5.8K in 2024 and -€4.9K in 2023. The 2025 profit margin improved to -83.8% from -119.7% in 2024, showing that losses narrowed relative to revenue, although profitability was still negative. The balance sheet stayed under pressure, with equity at -€25.7K and liabilities of €26.1K at the end of 2025. Total assets increased to €374, including €371 of long-term assets and €3 of short-term assets. Revenue per employee was €5.9K. Because the company’s equity and asset base are very small and equity remains negative, return and leverage ratios should be interpreted cautiously.